Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
1,2,3,4-tetrahydro-beta-carboline-1-carboxylic acid
- Development stage
- Preclinical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
1,2,3,4-Tetrahydro-beta-carboline-1-carboxylic acid is a small molecule research compound and a microbiota-derived postbiotic. It is primarily investigated for its neuroprotective, anti-inflammatory, and antioxidant properties. Mechanistically, it functions as an inhibitor of acetylcholinesterase, the enzyme responsible for the degradation of acetylcholine in the central nervous system, which has led to its study in the context of neurodegenerative disorders such as Alzheimer's disease. Recent research has also identified the compound as a postbiotic that may enhance the efficacy of standard chemotherapeutic agents, including gemcitabine and 5-fluorouracil, in treating pancreatic and colorectal cancers. While it is widely available from research chemical suppliers, it is not currently an approved therapeutic drug for any indication.
- Other names
- tetrahydro-beta-carboline carboxylic acid1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole-1-carboxylic acidTHC
02
Targets
Acetylcholinesterase
Beyond the preview
Go deeper on 1,2,3,4-tetrahydro-beta-carboline-1-carboxylic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 1,2,3,4-tetrahydro-beta-carboline-1-carboxylic acid.